Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT LIABILITIES (Details)

v3.24.2.u1
SELECTED FINANCIAL STATEMENT LIABILITIES (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Accounts payable:    
Clinical and regulatory expenses $ 749 $ 696
Professional fees 874 721
Selling expenses 2,253 1,498
Manufacturing costs 737 914
Non-employee director compensation 912 766
Other vendors 1,689 1,292
Total accounts payable 7,214 5,887
Accrued interest payable, related parties 705 542
Accrued interest payable 2,838 3,122
Accrued expenses:    
Payroll expenses 1,141 1,270
Government rebates and other rebates 6,938 5,881
Due to customers   844
Other accrued expenses 84 179
Total accrued expenses 8,163 8,174
Total accounts payable and accrued expenses $ 18,920 $ 17,725